Z Squared Completes SPAC Merger with Coeptis, Debuts on Nasdaq
Event summary
- Z Squared completed its business combination with Coeptis Therapeutics on April 24, 2026.
- The combined company will begin trading on Nasdaq under the ticker 'ZSQR' on April 27, 2026.
- Former Z Squared Opco stockholders now own ~85% of the company, with existing shareholders holding ~15%.
- Coeptis distributed its biopharmaceutical business interests to shareholders prior to the merger.
The big picture
Z Squared's Nasdaq debut follows a strategic pivot from biopharma to computing infrastructure, positioning it as a vertically integrated player in a sector increasingly focused on energy-efficient, scalable solutions. The merger consolidates control under former Z Squared Opco shareholders while setting the stage for expansion into new workloads and geographies. The company's facility-agnostic model aims to mitigate risks from localized disruptions, aligning with broader industry trends toward operational resilience.
What we're watching
- Geographic Expansion
- How Z Squared will leverage its distributed infrastructure model to scale into new regions.
- Power Cost Management
- Whether the company can sustain operational efficiency amid fluctuating energy markets.
- Market Timing
- The pace at which Z Squared can capitalize on current industry conditions post-listing.
Our editorial coverage:
Related topics